May 30, 2024

Prof. Cristina Granziera: Radio Interview on World Multiple Sclerosis Day

On May 30, 2024, to mark World Multiple Sclerosis Day, Prof. Cristina Granziera was the focus of an insightful interview on radio SFR1. During this comprehensive discussion, Prof. Granziera was invited as a leading expert in the field, and shared valuable information about the complexities of Multiple Sclerosis (MS), shedding light on its multifaceted nature.

Key Highlights from the SFR1 Interview:

Advancements in Diagnosis: Prof. Granziera explained that MS is an autoimmune disease where the immune system attacks the myelin layers in the brain. Over the past two decades, significant progress in imaging and the development of new biomarkers has improved the accuracy of MS diagnosis. This has led to an increase in the number of diagnosed cases, as more subtle signs of the disease can now be detected.

Increased Longevity and Quality of Life: One of the reasons for the rise in MS diagnoses is the improved therapies available today. Patients with MS are living longer and better lives due to these advancements, resulting in a higher number of individuals living with the condition.

Triggers and Causes: Despite intensive research, the exact cause of MS remains unknown. However, Prof. Granziera highlighted that factors such as viral infections, vitamin deficiencies (especially vitamin D), smoking, and genetic predisposition play roles in triggering MS. It is important to note that having a genetic predisposition does not guarantee that an individual will develop MS, as other environmental and lifestyle factors are involved.

Symptoms and When to Seek Medical Advice: MS is often called the “disease of a thousand faces” because its symptoms can vary widely. Common symptoms include visual disturbances, muscle weakness, dizziness, pain, and bladder disorders. Prof. Granziera emphasized the importance of seeking medical advice if any of these symptoms are experienced.

Current and Future Treatments: Currently, there is no cure for MS because the exact cause is still unknown. However, there are around 20 immunomodulating drugs available that can slow the progression of the disease and alleviate clinical symptoms.

Listen to the full interview on radio SFR1 and learn more about the ongoing fight against Multiple Sclerosis.

Listen to the original interview in German

Prof. Dr. Cristina Granziera: co-CEO of the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
© RC2NB 2025
crossmenuchevron-down